<DOC>
	<DOCNO>NCT00496938</DOCNO>
	<brief_summary>The purpose Clinical Evaluation continue assessment XIENCE Everolimus Eluting Coronary Stent System ( XIENCE V® XIENCE PRIME™ EECSS ) primary focus clinical outcome treatment female patient de novo coronary artery lesion , characterization female population undergo stent implantation XIENCE stent .</brief_summary>
	<brief_title>XIENCE V : SPIRIT WOMEN</brief_title>
	<detailed_description>SPIRIT Women Single-Arm Study : A prospective , open label , single arm , multi-center study evaluate performance XIENCE V® XIENCE PRIME™ EECSS treatment female patient coronary artery lesion , per Instructions Use ( IFU ) . The long term safety efficacy XIENCE V EECSS demonstrate SPIRIT FIRST trial 5 year , SPIRIT II trial 4 year , SPIRIT III Randomized Control Trial ( RCT ) 3 year . In addition , pre-approval study show low rate Target Vessel Failure Major Adverse Cardiac Events ( MACE ) observe plateau gradually decline 1 year consistently low comparator arm study . This benefit MACE sustain 5 year also independent first year result . The post approval SPIRIT V study demonstrate use XIENCE EECSS complex lesion real-world population result 1 year MACE , Stent Thrombosis Target Lesion Revascularization rate comparable previously mention pre-approval study include patient restrict inclusion / exclusion criterion . Therefore , base exist data trial , Abbott Vascular decide discontinue follow SPIRIT Women study 2 year .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Arteriosclerosis</mesh_term>
	<mesh_term>Coronary Stenosis</mesh_term>
	<mesh_term>Coronary Occlusion</mesh_term>
	<mesh_term>Coronary Restenosis</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<criteria>General Patient must female . Patient must least 18 year age . Patient able verbally confirm understand risk , benefit treatment alternative legally authorize representative provide write informed consent prior study related procedure , approve appropriate Medical Ethics Committee respective clinical site . Patient must evidence myocardial ischemia ( e.g. , stable unstable angina , silent ischemia , positive functional study reversible change electrocardiogram ( ECG ) consistent ischemia ) . Patient must acceptable candidate coronary artery bypass graft ( CABG ) surgery . Patient must agree undergo CIPrequired followup examination . Patients childbearing potential must negative pregnancy test within 7 day treatment , must nursing time treatment . Angiographic Patients ' artery morphology disease suitable optimally treat maximum 4 plan study stent . Target lesion must de novo lesion ( prior stent implant , prior brachytherapy ) . Target vessel reference diameter must 2.5 mm 4.0 mm visual estimate . The diameter range expand 2.25 mm 2.25 mm stent available . Target lesion great equal 28 mm length visual estimate . General Patient medical illness ( e.g. , cancer congestive heart failure ) know history substance abuse ( alcohol , cocaine , heroin etc . ) may cause noncompliance clinical investigation plan , confound data interpretation associate limited life expectancy ( i.e. , less one year ) . Patient known hypersensitivity contraindication aspirin , either heparin bivalirudin , clopidogrel ticlopidine , everolimus , cobalt , chromium , nickel , tungsten , acrylic fluoro polymer contrast sensitivity adequately premedicated . Participation another device drug study complete followup phase another study within last 30 day . Patient judge lesion prevents complete inflation angioplasty balloon . Patient previous stent implant , either Bare Metal Stent ( BMS ) Drug Eluting Stent ( DES ) within target vessel ( )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Stents</keyword>
	<keyword>Angioplasty</keyword>
	<keyword>Total coronary occlusion</keyword>
	<keyword>Coronary restenosis</keyword>
	<keyword>Stent thrombosis</keyword>
	<keyword>Everolimus</keyword>
</DOC>